Search clinical trials for: Nabiximols

Total 65 results

Hannover Medical School
German Research Foundation

Completed

CANNAbinoids in the Treatment of TICS (CANNA-TICS) (CANNA-TICS)

Tourette Syndrome | Tic Disorders

Germany
Ove Andersen
University of Copenhagen; Glostrup University Hospital, Copenhagen; University... and other collaborators

Recruiting

Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan) (CanPan)

Anorexia | Malnutrition | Aging | Pharmacokinetics | Cannabis | Renal Function | Emergency Service, Hospital

Denmark
Mary Lynch

Completed

Sativex for Treatment of Chemotherapy Induced Neuropathic Pain

Neuropathic Pain

Canada
S. Andrea Hospital
University of Roma La Sapienza

Unknown

Use of Cannabinoids in Patients With Multiple Sclerosis

Multiple Sclerosis

Italy
Jazz Pharmaceuticals

Completed

Study to Assess Food Effect on Sativex Bioavailability

Food Effect

United Kingdom
National Institute on Drug Abuse (NIDA)

Completed

Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation

Pharmacokinetics | Cannabis | Dependence | Cannabis Abuse | fMRI

United States
VA Office of Research and Development

Active, not recruiting

Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain

Diabetic Neuropathic Pain

United States
Almirall, S.A.

Completed

Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity (NS-MSS)

Multiple Sclerosis

Italy
Michael, Levy M.D.,Ph.D.
Jazz Pharmaceuticals

Not yet recruiting

A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders (SENS-NMO)

Spasticity, Muscle | NMO Spectrum Disorder

United States
University of Birmingham
University of Leeds; Jazz Pharmaceuticals; The Brain Tumour Charity

Recruiting

ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids (ARISTOCRAT)

Glioblastoma | Brain Tumor | Cannabis | Brain Tumor, Recurrent

United Kingdom
One World Cannabis Ltd.

Completed

Comparison of Safety, Tolerability and Pharmacokinetics of Medical Grade Cannabis (MGC) Orally Disintegrating Tablets With Buccal Sativex®, in Healthy Adult Volunteers

Healthy Subjects

Israel
Ospedale San Raffaele
University of Padova; Niguarda Hospital; Fondazione Salvatore Maugeri

Completed

Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease (CANALS)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis (ALS)

Italy
Jazz Pharmaceuticals

Completed

A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Multiple Sclerosis | Spasticity

United Kingdom
King's College London
South London and Maudsley NHS Foundation Trust

Completed

Experimental Medicine in ADHD - Cannabinoids (EMA-C)

Attention Deficit Hyperactivity Disorder (ADHD)

United Kingdom
IRCCS Centro Neurolesi "Bonino-Pulejo"

Completed

The Role of SAtivex® in Robotic-Rehabilitation (SARR)

Rehabilitation

Italy
Jens Rikardt Andersen
Augustinus Fonden; Københavns Universitet; Familien Hede Nielsens Fond

Withdrawn

The Effect of Cannabis in Pancreatic Cancer

Mortality | Cannabis | Cachexia; Cancer | Morbidity | Neoplasms Pancreatic | Palliative Medicine | Appetite Loss

Denmark
Jazz Pharmaceuticals

Completed

A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin

Pain | Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS

Multiple Sclerosis

Canada
Jazz Pharmaceuticals

Completed

Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain

Pain | Cancer

United Kingdom
Jazz Pharmaceuticals

Completed

Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients

Hepatic Impairment

United States
Jazz Pharmaceuticals

Withdrawn

A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.

Renal Insufficiency | Kidney Disease
Jazz Pharmaceuticals

Completed

A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis

Multiple Sclerosis | Detrusor Overactivity

United Kingdom
Jazz Pharmaceuticals

Completed

A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma

Cancer

United Kingdom
Jazz Pharmaceuticals

Completed

A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.

Pain | Peripheral Neuropathy

United Kingdom
Jazz Pharmaceuticals

Completed

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy (SPRAY)

Pain | Cancer | Palliative Care

United Kingdom
Jazz Pharmaceuticals

Completed

A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)

Multiple Sclerosis | Spasticity

United Kingdom
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer (SPRAY III)

Pain | Advanced Cancer

United States, Germany, United Kingdom, Mexico, Poland, Romania, Bulgaria, Czechia, Hungary, Puerto Rico
Jazz Pharmaceuticals

Completed

An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

An Observational Post-Marketing Safety Registry of Sativex®

Multiple Sclerosis | Diabetes | Cancer | Neuropathic Pain
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Pain | Advanced Cancer

Italy, United States, Taiwan, United Kingdom, Czechia, Bulgaria, Belgium, Latvia, Mexico, Lithuania, Poland, Romania, Hungary, Spain, Israel, Germany, Puerto Rico, Australia
Jazz Pharmaceuticals

Withdrawn

A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer

Advanced Cancer
Jazz Pharmaceuticals

Completed

A Study of the Long-term Safety of Sativex Use

Pain | Multiple Sclerosis | Spasticity

United Kingdom
Jazz Pharmaceuticals

Terminated

A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects

Healthy Volunteers
Jazz Pharmaceuticals

Completed

Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis

Multiple Sclerosis | Spasticity

United Kingdom
Jazz Pharmaceuticals

Completed

A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy

Pain | Diabetic Neuropathy

United Kingdom
Jazz Pharmaceuticals

Completed

A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis

Multiple Sclerosis | Neuropathic Pain

United Kingdom
Jazz Pharmaceuticals

Completed

An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Terminated

Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis (RELEASE MSS5)

Spasticity With Multiple Sclerosis

Spain, United States, United Kingdom, Czechia, Poland
Jazz Pharmaceuticals

Completed

A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients

Multiple Sclerosis | Spasticity

Czechia
Jazz Pharmaceuticals

Completed

A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia

Pain | Peripheral Neuropathy

United Kingdom
Jazz Pharmaceuticals

Completed

A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain

Pain | Peripheral Neuropathy

United Kingdom
Jazz Pharmaceuticals

Completed

A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.

Pain | Peripheral Neuropathy

United Kingdom
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

Pain | Advanced Cancer

United States, United Kingdom, Bulgaria, Belgium, Poland, Hungary, Romania, Czechia, Puerto Rico, Lithuania, Germany, Latvia
Jazz Pharmaceuticals

Completed

A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.

Multiple Sclerosis | Spasticity

United Kingdom
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer

Pain | Advanced Cancer

Israel, Italy, Taiwan, United Kingdom, Bulgaria, Hungary, India, Australia, Lithuania, Poland, Spain, Romania, Germany
Jazz Pharmaceuticals

Completed

A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury

Pain

United Kingdom
PhytoTech Therapeutics, Ltd.

Completed

5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy Volunteers

Healthy Volunteers

Israel
Jazz Pharmaceuticals

Terminated

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

Head and Neck Squamous Cell Carcinoma

United Kingdom
Jazz Pharmaceuticals

Completed

A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years

Cerebral Palsy

Czechia, Israel, United Kingdom

Search clinical trials for: Nabiximols

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations